These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6707879)

  • 1. Expanded solubility parameter approach. I: Naphthalene and benzoic acid in individual solvents.
    Beerbower A; Wu PL; Martin A
    J Pharm Sci; 1984 Feb; 73(2):179-88. PubMed ID: 6707879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended Hansen solubility approach: naphthalene in individual solvents.
    Martin A; Wu PL; Adjei A; Beerbower A; Prausnitz JM
    J Pharm Sci; 1981 Nov; 70(11):1260-4. PubMed ID: 7299673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanded solubility parameter approach. II: p-Hydroxybenzoic acid and methyl p-hydroxybenzoate in individual solvents.
    Martin A; Wu PL; Beerbower A
    J Pharm Sci; 1984 Feb; 73(2):188-94. PubMed ID: 6707880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial solubility parameters and solvatochromic parameters for predicting the solubility of single and multiple drugs in individual solvents.
    Bustamante P; Martin A; Gonzalez-Guisandez MA
    J Pharm Sci; 1993 Jun; 82(6):635-40. PubMed ID: 8331539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended Hansen approach: calculating partial solubility parameters of solid solutes.
    Wu PL; Beerbower A; Martin A
    J Pharm Sci; 1982 Nov; 71(11):1285-7. PubMed ID: 7175725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The modified extended Hansen method to determine partial solubility parameters of drugs containing a single hydrogen bonding group and their sodium derivatives: benzoic acid/Na and ibuprofen/Na.
    Bustamante P; Pena MA; Barra J
    Int J Pharm; 2000 Jan; 194(1):117-24. PubMed ID: 10601690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the solubility of sulfamethoxypyridazine in individual solvents. I: Calculating partial solubility parameters.
    Bustamante P; Escalera B; Martin A; Sellés E
    J Pharm Sci; 1989 Jul; 78(7):567-73. PubMed ID: 2778657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial solubility parameters of lactose, mannitol and saccharose using the modified extended Hansen method and evaporation light scattering detection.
    Peña MA; Daali Y; Barra J; Bustamante P
    Chem Pharm Bull (Tokyo); 2000 Feb; 48(2):179-83. PubMed ID: 10705501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dependence of solute solubility parameters on solvent polarity.
    Martin A; Wu PL; Liron Z; Cohen S
    J Pharm Sci; 1985 Jun; 74(6):638-42. PubMed ID: 3839531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between swelling of hydroxypropylmethylcellulose and the Hansen and Karger partial solubility parameters.
    Navarro-Lupión FJ; Bustamante P; Escalera B
    J Pharm Sci; 2005 Jul; 94(7):1608-16. PubMed ID: 15920774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposition of group molar constants for sodium to calculate the partial solubility parameters of sodium salts using the van Krevelen group contribution method.
    Barra J; Peña MA; Bustamante P
    Eur J Pharm Sci; 2000 Apr; 10(2):153-61. PubMed ID: 10727881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial-solubility parameters of naproxen and sodium diclofenac.
    Bustamante P; Peña MA; Barra J
    J Pharm Pharmacol; 1998 Sep; 50(9):975-82. PubMed ID: 9811157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mobile order theory versus UNIFAC and regular solution theory-derived models for predicting the solubility of solid substances.
    Ruelle P; Buchmann M; Hô NT; Kesselring UW
    Pharm Res; 1992 Jun; 9(6):788-91. PubMed ID: 1409362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the solubility of sulfamethoxypyridazine in individual solvents. II: Relationship between solute-solvent interaction terms and partial solubility parameters.
    Martin A; Bustamante P; Escalera B; Sellés E
    J Pharm Sci; 1989 Aug; 78(8):672-8. PubMed ID: 2778673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expanded Hansen approach to solubility parameters. Paracetamol and citric acid in individual solvents.
    Barra J; Lescure F; Doelker E; Bustamante P
    J Pharm Pharmacol; 1997 Jul; 49(7):644-51. PubMed ID: 9255705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermochemical investigations of nearly ideal binary solvents. VII: Monomer and dimer models for solubility of benzoic acid in simple binary and ternary solvents.
    Acree WE; Bertrand GL
    J Pharm Sci; 1981 Sep; 70(9):1033-6. PubMed ID: 6101149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamics of solutions I: benzoic acid and acetylsalicylic acid as models for drug substances and the prediction of solubility.
    Perlovichl GL; Bauer-Brandl A
    Pharm Res; 2003 Mar; 20(3):471-8. PubMed ID: 12669971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended solubility approach: solubility parameters for crystalline solid compounds.
    Martin A; Carstensen J
    J Pharm Sci; 1981 Feb; 70(2):170-2. PubMed ID: 7205222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicomponent solubility parameters for single-walled carbon nanotube-solvent mixtures.
    Bergin SD; Sun Z; Rickard D; Streich PV; Hamilton JP; Coleman JN
    ACS Nano; 2009 Aug; 3(8):2340-50. PubMed ID: 19655724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended Hildebrand Solubility Approach: methylxanthines in mixed solvents.
    Martin A; Paruta AN; Adjei A
    J Pharm Sci; 1981 Oct; 70(10):1115-20. PubMed ID: 7299644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.